Also on Trial Friend:Chronic Inflammatory Demyelinating Polyneuropathy pageMatch Me
All 35 Chronic Inflammatory Demyelinating Polyneuropathy trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)Most sites in Texas, California and ArizonaRecruitingPhase 3Ages 18-75Dianthus Therapeutics32US sites
20 states - A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Most sites in New York, Florida and TexasRecruitingPhase 3Ages 18+Sanofi32US sites
21 states - Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Most sites in California, Florida and District of ColumbiaRecruitingPhase 2Ages 18+Immunovant Sciences32US sites
19 states - A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDPMost sites in Florida, Pennsylvania and TexasRecruitingPhase 3Ages 18+argenx18US sites
14 states - A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Most sites in North Carolina, Florida and ArizonaRecruitingPhase 3Ages 18+Takeda16US sites
12 states - A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Most sites in Florida, California and MissouriRecruitingPhase 2Ages 18+Takeda15US sites
10 states - A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPMost sites in Florida, Pennsylvania and TexasRecruitingPhase 3Ages 18+argenx14US sites
10 states - A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical CareMost sites in California, Florida and ConnecticutRecruitingAges 18+Takeda9US sites
7 states - A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyMost sites in Florida, Texas and CaliforniaRecruitingPhase 3Ages 18+Grifols Therapeutics8US sites
6 states - A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Most sites in Florida, Connecticut and New HampshireRecruitingPhase 3Ages 18+Kedrion S.p.A.6US sites
4 states - Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) PatientsMost sites in Alabama, California and KentuckyRecruitingPhase 3Ages 2-17Octapharma6US sites
6 states - Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual TreatmentMost sites in California, New York and UtahRecruitingPhase 1Ages 18-75Kite, A Gilead Company5US sites
4 states - Two Dose Levels of Privigen in Pediatric CIDPMost sites in Pennsylvania, Texas and WashingtonRecruitingPhase 4Ages 2-17CSL Behring3US sites
3 states - A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.Only in West VirginiaRecruitingargenx1US site
- Biorepository and Registry for Plasma Exchange PatientsOnly in IowaRecruitingAges 12-99Charles M Knudson1US site
- IVIG vs SCIG in CIDPOnly in New JerseyRecruitingPhase 1Ages 18-65Rutgers, The State University of New Jersey1US site
- Real-World Efgartigimod Effectiveness in CIDP: A Prospective StudyOnly in North CarolinaRecruitingAges 18+argenx1US site
- Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)Only in PennsylvaniaRecruitingAges 18+Sanofi1US site
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingAges 18+Tongji HospitalNo US site yet
- CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune DiseasesRecruitingEarly Phase 1Ages 18-70Tongji HospitalNo US site yet
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Chronic Inflammatory Demyelinating Polyneuropathy trials in the US, and what stage they are in
Of the 18 Chronic Inflammatory Demyelinating Polyneuropathy trials with a US site, 8 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 4 of them. One is a Phase 4 study of an already approved treatment. The remaining 5 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 16 of them, and universities, hospitals, foundations and government groups run 2. The sponsors with the most are argenx (4), Takeda (3) and Sanofi (2). The most recently listed one first appeared on ClinicalTrials.gov on April 20, 2026.
Chronic Inflammatory Demyelinating Polyneuropathy trials in the US, state by state
Of the 18 Chronic Inflammatory Demyelinating Polyneuropathy trials with a US site, 4 accept children under 18. Their open sites are in 9 states, most often Pennsylvania, Texas and Alabama. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 27 states
US hospitals running the most Chronic Inflammatory Demyelinating Polyneuropathy trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Chronic Inflammatory Demyelinating Polyneuropathy.
- Banner University of Arizona Medical CenterTucson, Arizona2 trials
- Colorado Springs Neurological AssociatesColorado Springs, Colorado2 trials
- Jefferson Health Honickman CenterPhiladelphia, Pennsylvania2 trials
- Knight NeurologyRockledge, Florida2 trials
- NeuroCarePlusHouston, Texas2 trials
- Paradigm Health SystemSlidell, Louisiana2 trials
- Stanford Neuroscience Health CenterPalo Alto, California2 trials
- The Washington UniversitySt Louis, Missouri2 trials
- University NeurologyKnoxville, Tennessee2 trials
- University of South FloridaTampa, Florida2 trials
Help getting to a Chronic Inflammatory Demyelinating Polyneuropathy trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Chronic Inflammatory Demyelinating Polyneuropathy trial near you
Are there Chronic Inflammatory Demyelinating Polyneuropathy clinical trials near me?
As of November 13, 2026, 35 Chronic Inflammatory Demyelinating Polyneuropathy clinical trials are recruiting now and 8 are not yet recruiting. In the US, 18 of them have at least 1 open site, across 36 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Chronic Inflammatory Demyelinating Polyneuropathy clinical trial sites?
Recruiting Chronic Inflammatory Demyelinating Polyneuropathy trials list open sites in 36 states and Washington, DC. California, Florida and Texas have the most, and the table on this page lists every state.
Are there Chronic Inflammatory Demyelinating Polyneuropathy trials for children near me?
Of the 18 Chronic Inflammatory Demyelinating Polyneuropathy trials with a US site, 4 accept children under 18. Their open sites are in 9 states, most often Pennsylvania, Texas and Alabama. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Chronic Inflammatory Demyelinating Polyneuropathy clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Chronic Inflammatory Demyelinating Polyneuropathy trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Chronic Inflammatory Demyelinating Polyneuropathy trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Chronic Inflammatory Demyelinating Polyneuropathy: Immune globulin (immune globulin (human)), VYVGART Hytrulo (efgartigimod alfa and hyaluronidase (human recombinant)).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.
